PreDiagnose ApS: Financial statements 2025
CVR: 38562770
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
PreDiagnose ApS (CVR 38562770) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 129,206 and a net result of DKK 2,564 compared with DKK 60,353 the year before. That is an increase of 81.9% compared with the year before. Equity in the 2025 report amounted to DKK 1,203,779. The solvency ratio was 80.9%.
- Gross Profit
- DKK 129,206
- Profit/Loss
- DKK 2,564
- Equity
- DKK 1,203,779
- Total Assets
- DKK 1,487,501
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 129 t. | 3 t. | 1.2 mio. | 0 |
| 2024 | - | 71 t. | 60 t. | 1.2 mio. | 0 |
| 2023 | - | 53 t. | 40 t. | 1.1 mio. | 1 |
| 2022 | - | 85 t. | -64 t. | 1.1 mio. | 1 |
| 2021 | - | 574 t. | 453 t. | 1.2 mio. | 3 |
Official annual report
How creditworthy is PreDiagnose ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
PreDiagnose ApS has published its annual report for 2024. Gross profit came to DKK 71,026, and the net result was DKK 60,353.
About PreDiagnose ApS
PreDiagnose ApS is a Danish company of the type Anpartsselskab based in Karlslunde, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named PreDiagnose IVS. The management consists of Fatima Al-Zahraa Al Atraktchi. The company is owned by FZA ApS. The company has 1 employee (2023). In 2025, the company reported a gross profit of DKK 129,206 and a net result of DKK 2,564 compared with DKK 60,353 the year before. Equity in the 2025 report amounted to DKK 1,203,779.